Neuroleptic Malignant Syndrome: A Primary Care Perspective


Forgot your login? GET HELP

In recent years, there has been an increased use of neuroleptic agents in the primary care setting. Neuroleptic malignant syndrome (NMS) is a rare complication of neuroleptic therapy that can be missed if not suspected. This manuscript reviews the diagnosis and management of NMS in the primary care setting. There is a lack of prospective data, and most of the information is obtained from case series. Physicians need to have a high index of suspicion with regard to excluding NMS in patients taking neuroleptics and presenting with hyperthermia.

Prim Care Companion J Clin Psychiatry 2004;6(5):191-194

https://doi.org/10.4088/PCC.v06n0502